Strategic partnerships Planet Innovation collaborates with leading biotech firms such as Quantum-Si and LevitasBio to design and manufacture advanced diagnostics and cell isolation systems, signaling opportunities to offer end-to-end product development, testing, and scale-up services for similar high-growth customers.

Manufacturing capacity With a substantial team and a revenue range of 100–250 million, Planet Innovation has proven manufacturing capabilities and a track record of rapid responsiveness, suggesting they can support rapid scale and COVID-19–related or surge-demand health tech programs for new clients.

Healthcare vertical Specialization in diagnostics, life sciences, and healthcare product development creates cross-sell potential into adjacent segments such as point-of-care devices, enabling components, and regulatory-ready manufacturing pipelines for prospective customers expanding in healthtech.

Global expansion footprint Recent expansions and partnerships in Victoria, Australia, and across Oceania indicate readiness to deploy regional manufacturing hubs, offering a compelling case to prospective customers seeking localized production, supply-chain resilience, and regional regulatory support.

Digital and compliance readiness Adoption of Microsoft Dynamics 365 Finance, Azure DevOps, Azure AD, and secure e-signature tools demonstrates strong process automation and compliance capabilities, providing a selling point for clients needing validated, scalable operations and accelerated time-to-market.